Enhertu approved in EU in post-ET breast cancer
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Awards highlight Avantor's commitment to the Biopharma industry
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Founded in 2023, Spectrum Vascular acquired the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Subscribe To Our Newsletter & Stay Updated